![Keeren Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keeren Shah
Financieel Directeur/CFO bij
ACTAVIA LIFE SCIENCES, INC.
Vermogen: 24 275 $ op 30-09-2026
Profiel
Keeren Shah is currently a Member at The Chartered Institute of Management Accountants.
Serving as Chief Financial Officer at Actavia Life Sciences, Inc. since 2020.
Chief Financial Officer at OKYO Pharma Ltd. since 2020.
Chief Financial Officer at AccuStem Sciences, Inc. since 2021.
Chief Operating & Financial Officer at Tiziana Life Sciences Ltd. (Bermuda).
Chief Financial Officer at Tiziana Life Sciences Ltd. (United Kingdom).
Formerly Finance Director at Rasna Therapeutics, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
OKYO PHARMA LIMITED 0,03% | 19-06-2026 | 16.667 ( 0,03% ) | 21 500 $ | 30-09-2026 |
| 31-03-2026 | 2.500 ( 0% ) | 2 775 $ | 30-09-2026 |
Actieve functies van Keeren Shah
| Bedrijven | Functie | Begin |
|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Financieel Directeur/CFO | 31-07-2020 |
| WEST AFRICAN MINERALS CORP | Financieel Directeur/CFO | 01-08-2020 |
| ACCM SCIE | Financieel Directeur/CFO | 01-08-2021 |
| TIZIANA LIFE SCIENCES LTD | Financieel Directeur/CFO | 01-03-2021 |
The Chartered Institute of Management Accountants
 The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services College/University | Corporate Officer/Principal | - |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Financieel Directeur/CFO | - |
Eerdere bekende functies van Keeren Shah
| Bedrijven | Functie | Einde |
|---|---|---|
Rasna Therapeutics, Inc. /Old/
 Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Develops cancer drugs | Financieel Directeur/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
49
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services College/University | Consumer Services |
OKYO Pharma Ltd.
 OKYO Pharma Ltd. BiotechnologyHealth Technology Develops next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases | Health Technology |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Health Technology |
Rasna Therapeutics, Inc. /Old/
Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Develops cancer drugs | Distribution Services |
Actavia Life Sciences, Inc.
 Actavia Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
AccuStem Sciences, Inc.
 AccuStem Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomics-based personalized medicines for breast cancer patients | Health Technology |
Tiziana Life Sciences Ltd.
 Tiziana Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
